Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma

Breast Cancer Research and Treatment

Volumn 129, Issue 3, 2011, Pages 725-736

  Hartog, Hermien ^a   Horlings, Hugo M ^b   Van Der Vegt, Bert ^a   Kreike, Bas ^b   Ajouaou, Abderrahim ^b   Van De Vijver, Marc J ^c   Marike Boezen, H ^a   De Bock, Geertruida H ^a   Van Der Graaf, Winette T A ^d   Wesseling, Jelle ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Ductal type; Estrogen receptor; Insulin like growth factor type 1 receptor; Prognosis; Triple negative breast tumors

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; SOMATOMEDIN C RECEPTOR; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER SPECIFIC SURVIVAL; BREAST SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CYTOPLASM; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; INVASIVE DUCTAL BREAST CARCINOMA; MAJOR CLINICAL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 80052583009     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1256-6     Document Type: Article

References (58)

1. H Hartog J Wesseling HM Boezen WT van der Graaf 2007 The insulin-like growth factor 1 receptor in cancer: old focus, new future Eur J Cancer 43 1895 1904 17624760 10.1016/j.ejca.2007.05.021 1:CAS:528:DC%2BD2sXpsFKntbk%3D (Pubitemid 47284866)
2. M Pollak 2008 Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 915 928 19029956 10.1038/nrc2536 1:CAS:528: DC%2BD1cXhsVWhu7rL
3. BD Cohen DA Baker C Soderstrom G Tkalcevic AM Rossi PE Miller MW Tengowski F Wang A Gualberto JS Beebe JD Moyer 2005 Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751, 871 Clin Cancer Res 11 2063 2073 15756033 10.1158/1078-0432.CCR-04-1070 1:CAS:528:DC%2BD2MXitVKrtr0%3D (Pubitemid 40471873)
4. A Milano LagoL Dal C Sotiriou M Piccart F Cardoso 2006 What clinicians need to know about antioestrogen resistance in breast cancer therapy Eur J Cancer 42 2692 2705 16963260 10.1016/j.ejca.2006.06.022 1:CAS:528: DC%2BD28XhtFSrtbzE (Pubitemid 44584668)
5. R Nahta LX Yuan B Zhang R Kobayashi FJ Esteva 2005 Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells Cancer Res 65 11118 11128 16322262 10.1158/0008-5472.CAN-04-3841 1:CAS:528:DC%2BD2MXht1KjsrrI (Pubitemid 41713383)
6. SR Hubbard WT Miller 2007 Receptor tyrosine kinases: mechanisms of activation and signaling Curr Opin Cell Biol 19 117 123 17306972 10.1016/j.ceb.2007.02.010 1:CAS:528:DC%2BD2sXjt1Slu78%3D (Pubitemid 46386407)
7. J Dupont D LeRoith 2001 Insulin and insulin-like growth factor I receptors: similarities and differences in signal transduction Horm Res 55 2 22 26 11684871 10.1159/000063469 1:CAS:528:DC%2BD3MXnvVCktrw%3D (Pubitemid 34701919)
8. JI Jones DR Clemmons 1995 Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 16 3 34 7758431 1:CAS:528: DyaK2MXltlKhu7g%3D
9. MM Weber C Fottner SB Liu MC Jung D Engelhardt GB Baretton 2002 Overexpression of the insulin-like growth factor I receptor in human colon carcinomas Cancer 95 2086 2095 12412161 10.1002/cncr.10945 1:CAS:528: DC%2BD38XptVKntLg%3D (Pubitemid 35253369)
10. YM Chong K Colston WG Jiang AK Sharma K Mokbel 2006 The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue Breast Cancer Res Treat 99 275 288 16752221 10.1007/s10549-006-9215-y 1:CAS:528:DC%2BD28XptVWqsLg%3D (Pubitemid 44337919)
11. C Garcia-Echeverria MA Pearson A Marti T Meyer J Mestan J Zimmermann J Gao J Brueggen HG Capraro R Cozens DB Evans D Fabbro P Furet DG Porta J Liebetanz G Martiny-Baron S Ruetz F Hofmann 2004 In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase Cancer Cell 5 231 239 15050915 10.1016/S1535-6108(04)00051-0 1:CAS:528: DC%2BD2cXjtVartbk%3D (Pubitemid 38402115)
12. P Haluska JM Carboni DA Loegering FY Lee M Wittman MG Saulnier DB Frennesson KR Kalli CA Conover RM Attar SH Kaufmann M Gottardis C Erlichman 2006 In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417 Cancer Res 66 362 371 16397250 10.1158/0008-5472.CAN-05-1107 1:CAS:528:DC%2BD28XhsFWnuw%3D%3D (Pubitemid 43166043)
13. CS Mitsiades NS Mitsiades CJ McMullan V Poulaki R Shringarpure M Akiyama T Hideshima D Chauhan M Joseph TA Libermann C Garcia-Echeverria MA Pearson F Hofmann KC Anderson AL Kung 2004 Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors Cancer Cell 5 221 230 15050914 10.1016/S1535-6108(04)00050-9 1:CAS:528:DC%2BD2cXjtVartbg%3D (Pubitemid 38402114)
14. Pandini G, Wurch T, Akla B, Corvaia N, Belfiore A, Goetsch L (2007) Functional responses and in vivo anti-tumour activity of h7C10: a humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors. Eur J Cancer 43:1318-1327 (Pubitemid 46720250)
15. A Camirand Y Lu M Pollak 2002 Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells Med Sci Monit 8 BR521 BR526 12503030 1:CAS:528:DC%2BD3sXhtVGiu74%3D
16. AK Chakraborty K Liang MP DiGiovanna 2008 Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer Cancer Res 68 1538 1545 18316619 10.1158/0008-5472.CAN-07-5935 1:CAS:528:DC%2BD1cXislansr8%3D (Pubitemid 351346863)
17. HE Jones L Goddard JM Gee S Hiscox M Rubini D Barrow JM Knowlden S Williams AE Wakeling RI Nicholson 2004 Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells Endocr Relat Cancer 11 793 814 15613453 10.1677/erc.1.00799 1:CAS:528:DC%2BD2MXhtVartrs%3D (Pubitemid 40065552)
18. M Bartucci C Morelli L Mauro S Ando E Surmacz 2001 Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells Cancer Res 61 6747 6754 11559546 1:CAS:528:DC%2BD3MXntFaisL0%3D (Pubitemid 32896497)
19. S Oesterreich P Zhang RL Guler X Sun EM Curran WV Welshons CK Osborne AV Lee 2001 Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth Cancer Res 61 5771 5777 11479214 1:CAS:528:DC%2BD3MXlvVCgtbw%3D (Pubitemid 32769093)
20. D Yee AV Lee 2000 Crosstalk between the insulin-like growth factors and estrogens in breast cancer J Mammary Gland Biol Neoplasia 5 107 115 10791773 10.1023/A:1009575518338 1:STN:280:DC%2BD3c3ltVCgtw%3D%3D
21. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687-1717
22. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lonning PO Brown AL Borresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
23. LC Happerfield DW Miles DM Barnes LL Thomsen P Smith A Hanby 1997 The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue J Pathol 183 412 417 9496257 10.1002/(SICI)1096- 9896(199712)183:4<412::AID-PATH944>3.0.CO;2-4 1:STN:280: DyaK1c7lslensA%3D%3D (Pubitemid 27509247)
24. M Koda W Przystupa K Jarzabek A Wincewicz L Kanczuga-Koda J Tomaszewski M Sulkowska S Wolczynski S Sulkowski 2005 Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer Oncol Rep 14 93 98 15944774 1:CAS:528:DC%2BD2MXmt1Chtbg%3D
25. TO Nielsen HN Andrews M Cheang JE Kucab FD Hsu J Ragaz CB Gilks N Makretsov CD Bajdik C Brookes LM Neckers V Evdokimova DG Huntsman SE Dunn 2004 Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin Cancer Res 64 286 291 14729636 10.1158/0008-5472.CAN-03-1242 1:CAS:528:DC%2BD2cXkslyktg%3D%3D (Pubitemid 38114109)
26. C Shimizu T Hasegawa Y Tani F Takahashi M Takeuchi T Watanabe M Ando N Katsumata Y Fujiwara 2004 Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis Hum Pathol 35 1537 1542 15619214 10.1016/j.humpath.2004.09.005 1:CAS:528:DC%2BD2cXhtVyku7%2FE (Pubitemid 40017995)
27. S Ueda H Tsuda K Sato H Takeuchi T Shigekawa O Matsubara H Hiraide H Mochizuki 2006 Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin-like growth factor receptor type 1 Cancer Sci 97 597 604 16827799 10.1111/j.1349-7006.2006.00228.x 1:CAS:528:DC%2BD28XmsVOnt7c%3D (Pubitemid 44056607)
28. B Schnarr K Strunz J Ohsam A Benner J Wacker D Mayer 2000 Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer Int J Cancer 89 506 513 11102895 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F 1:CAS:528:DC%2BD3cXptVejs74%3D
29. O Fadare FA Tavassoli 2008 Clinical and pathologic aspects of basal-like breast cancers Nat Clin Pract Oncol 5 149 159 18212769 10.1038/ncponc1038
30. Tavassoli FA, Devilee P (2003) World Health Organization classification of tumours pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon
31. B Kreike M van Kouwenhove H Horlings B Weigelt H Peterse H Bartelink MJ van de Vijver 2007 Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas Breast Cancer Res 9 R65 17910759 10.1186/bcr1771 (Pubitemid 350187481)
32. RL Camp LA Charette DL Rimm 2000 Validation of tissue microarray technology in breast carcinoma Lab Invest 80 1943 1949 11140706 10.1038/labinvest.3780204 1:STN:280:DC%2BD3M%2Foslamsg%3D%3D (Pubitemid 32012762)
33. J Kononen L Bubendorf A Kallioniemi M Barlund P Schraml S Leighton J Torhorst MJ Mihatsch G Sauter OP Kallioniemi 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844 847 9662379 10.1038/nm0798-844 1:CAS:528:DyaK1cXktlKntr8%3D (Pubitemid 28331029)
34. B van der Vegt MA de Roos JL Peterse C Patriarca J Hilkens GH de Bock J Wesseling 2007 The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma Histopathology 51 322 335 17645748 10.1111/j.1365-2559.2007.02757.x (Pubitemid 47301607)
35. RX Song Y Chen Z Zhang Y Bao W Yue JP Wang P Fan RJ Santen 2010 Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells J Steroid Biochem Mol Biol 118 219 230 19815064 10.1016/j.jsbmb.2009.09.018 1:CAS:528:DC%2BC3cXitlSltLc%3D
36. M Broussas J Dupont A Gonzalez A Blaecke M Fournier N Corvaia L Goetsch 2009 Molecular mechanisms involved in activity of h7C10, a humanized monoclonal antibody, to IGF-1 receptor Int J Cancer 124 2281 2293 19165858 10.1002/ijc.24186 1:CAS:528:DC%2BD1MXltFaqsbg%3D
37. CY Lee JH Jeon HJ Kim DH Shin TW Roh CM Ahn YS Chang 2008 Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis Korean J Intern Med 23 116 120 18787363 10.3904/kjim.2008.23.3.116
38. MP Cunningham S Essapen H Thomas M Green DP Lovell C Topham C Marks H Modjtahedi 2006 Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients Int J Oncol 28 329 335 16391786
39. M Nakamura S Miyamoto H Maeda SC Zhang T Sangai G Ishii T Hasebe Y Endoh N Saito M Asaka A Ochiai 2004 Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers Clin Cancer Res 10 8434 8441 15623623 10.1158/1078-0432.CCR-04-0430 1:CAS:528:DC%2BD2cXhtFGjs73F (Pubitemid 40053407)
40. T Wallborn S Wuller J Klammt T Kruis J Kratzsch G Schmidt M Schlicke E Muller HS van de Leur W Kiess R Pfaffle 2010 A heterozygous mutation of the insulin-like growth factor-I receptor causes retention of the nascent protein in the endoplasmic reticulum and results in intrauterine and postnatal growth retardation J Clin Endocrinol Metab 95 2316 2324 20357178 10.1210/jc.2009-2404 1:CAS:528:DC%2BC3cXmtFensrY%3D
41. B Sehat A Tofigh Y Lin E Trocme U Liljedahl J Lagergren O Larsson 2010 SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor Sci Signal 3 ra10 20145208 10.1126/scisignal.2000628
42. T Aleksic MM Chitnis OV Perestenko S Gao PH Thomas GD Turner AS Protheroe M Howarth VM Macaulay 2010 Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells Cancer Res 70 6412 6419 20710042 10.1158/0008-5472.CAN-10-0052 1:CAS:528:DC%2BC3cXhtVWqu7jO
43. Y Wang J Hailey D Williams Y Wang P Lipari M Malkowski X Wang L Xie G Li D Saha WL Ling S Cannon-Carlson R Greenberg RA Ramos R Shields L Presta P Brams WR Bishop JA Pachter 2005 Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody Mol Cancer Ther 4 1214 1221 16093437 10.1158/1535-7163.MCT- 05-0048 1:CAS:528:DC%2BD2MXnt1ShtLg%3D (Pubitemid 41149569)
44. JP Peyrat J Bonneterre R Beuscart J Djiane A Demaille 1988 Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors Cancer Res 48 6429 6433 2972358 1:CAS:528: DyaL1MXlsFWi
45. MJ Railo K Von Smitten F Pekonen 1994 The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients Eur J Cancer 30A 307 311 8204350 10.1016/0959-8049(94) 90247-X 1:STN:280:DyaK2c3mtlKlsA%3D%3D (Pubitemid 24152469)
46. AG Renehan M Zwahlen C Minder ST O'dwyer SM Shalet M Egger 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 1346 1353 15110491 10.1016/S0140-6736(04)16044-3 1:CAS:528:DC%2BD2cXjtl2lsL0%3D (Pubitemid 38529873)
47. AG Renehan M Egger C Minder ST O'dwyer SM Shalet M Zwahlen 2005 IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses Int J Cancer 115 1006 1007 15723358 10.1002/ijc.20975 1:CAS:528:DC%2BD2MXltlWrsbg%3D (Pubitemid 40791842)
48. TJ Key PN Appleby GK Reeves AW Roddam 2010 Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies Lancet Oncol 11 530 542 20472501 10.1016/S1470-2045(10)70095-4
49. JP Parisot KS Leeding XF Hu M DeLuise JR Zalcberg LA Bach 1999 Induction of insulin-like growth factor binding protein expression by ICI 182, 780 in a tamoxifen-resistant human breast cancer cell line Breast Cancer Res Treat 55 231 242 10517168 10.1023/A:1006274712664 1:CAS:528:DyaK1MXmslGhs7Y%3D (Pubitemid 29425576)
50. JP Parisot XF Hu M DeLuise JR Zalcberg 1999 Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line Br J Cancer 79 693 700 10070856 10.1038/sj.bjc.6690112 1:CAS:528:DyaK1MXhslCns7s%3D (Pubitemid 29082092)
51. J Brugge MC Hung GB Mills 2007 A new mutational AKTivation in the PI3K pathway Cancer Cell 12 104 107 17692802 10.1016/j.ccr.2007.07.014 1:CAS:528:DC%2BD2sXps1artrY%3D (Pubitemid 47199129)
52. K Berns HM Horlings BT Hennessy M Madiredjo EM Hijmans K Beelen SC Linn AM Gonzalez-Angulo K Stemke-Hale M Hauptmann RL Beijersbergen GB Mills MJ van de Vijver R Bernards 2007 A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer Cancer Cell 12 395 402 17936563 10.1016/j.ccr.2007.08.030 1:CAS:528:DC%2BD2sXht1ais7zL (Pubitemid 47539306)
53. CJ Creighton A Casa Z Lazard S Huang A Tsimelzon SG Hilsenbeck CK Osborne AV Lee 2008 Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis J Clin Oncol 26 4078 4085 18757322 10.1200/JCO.2007.13.4429 1:CAS:528:DC%2BD1cXhtFKisLfI
54. AM Mulligan FP O'Malley M Ennis IG Fantus PJ Goodwin 2007 Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer Breast Cancer Res Treat 106 39 47 17221153 10.1007/s10549-006- 9471-x 1:CAS:528:DC%2BD2sXhtFSmu7rI (Pubitemid 47498088)
55. MC Mathieu GM Clark DC Allred ID Goldfine R Vigneri 1997 Insulin receptor expression and clinical outcome in node-negative breast cancer Proc Assoc Am Physicians 109 565 571 9394418 1:CAS:528:DyaK2sXns1Omu7Y%3D (Pubitemid 27495695)
56. JH Law G Habibi K Hu H Masoudi MY Wang AL Stratford E Park JM Gee P Finlay HE Jones RI Nicholson J Carboni M Gottardis M Pollak SE Dunn 2008 Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival Cancer Res 68 10238 10246 19074892 10.1158/0008-5472.CAN-08-2755 1:CAS:528:DC%2BD1cXhsV2itL7K
57. A Klinakis M Szabolcs G Chen S Xuan H Hibshoosh A Efstratiadis 2009 Igf1r as a therapeutic target in a mouse model of basal-like breast cancer Proc Natl Acad Sci USA 106 2359 2364 19174523 10.1073/pnas.0810221106 1:CAS:528: DC%2BD1MXit1yqurc%3D
58. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2005 Reporting recommendations for tumor marker prognostic studies J Clin Oncol 23 9067 9072 16172462 10.1200/JCO.2004.01.0454